This article is more than 5 years old. Information may no longer be current.
Foundation to launch study on Stargardt’s disease
The Foundation Fighting Blindness Clinical Research Institute announced the start of a study of people affected by Stargardt’s disease, according to a foundation press release.
The Natural History of the Progression of Atrophy Secondary to Stargardt’s Disease: A Longitudinal Observational Study (ProgStar) aims to determine the best outcome measures to accelerate evaluation of emerging treatments, better understand disease progression for selecting future clinical trial participants and identify potential participants for forthcoming clinical trials, according to the release.
The study will combine both prospective and retrospective analyses, the release said.
Primary outcome measures will be retinal images, visual fields and visual acuity, it said.
ProgStar will be enrolling its first participants in the spring or summer of 2013, pending regulatory approval to proceed. The study’s nine clinicians will recruit about 250 total participants from their existing patient bases, according to the release.